NCT05049135

Brief Summary

To evaluate the feasibility of a sensor-less sleep monitor (Somnofy®) in diagnosis and follow-up in obstructive sleep apnea. The study will explore the monitor's usefulness in detection of apnea during sleep, and compare the data to standard diagnostic registrations.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
65

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Sep 2021

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 1, 2021

Completed
8 days until next milestone

First Submitted

Initial submission to the registry

September 9, 2021

Completed
8 days until next milestone

First Posted

Study publicly available on registry

September 17, 2021

Completed
1.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2022

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

March 7, 2023

Completed
Last Updated

March 20, 2023

Status Verified

March 1, 2023

Enrollment Period

1.3 years

First QC Date

September 9, 2021

Last Update Submit

March 16, 2023

Conditions

Keywords

sleep monitor

Outcome Measures

Primary Outcomes (1)

  • Apnea/hypopnea index

    Apnea/hypopnea index defined as the number of apneas or hypopneas per hours of sleep

    72 hours

Secondary Outcomes (1)

  • Sleep score

    12 weeks

Study Arms (2)

Sleep apnea group

Patients with undiagnosed suspected sleep apnea who are referred to Levanger Hospital for respiratory polygraphy

Device: Somnofy® sleep monitor

Control group

partners of patients with undiagnosed suspected sleep apnea who are referred to Levanger Hospital for respiratory polygraphy

Device: Somnofy® sleep monitor

Interventions

Registration of sleep score and apneas with radar sensor technology at time of primary investigation and 12 weeks after treatment initiation with continuous positive airway pressure (CPAP)

Also known as: Respiratory polygraphy (NOXT3, ResMed AS)
Control groupSleep apnea group

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patents with undiagnosed suspected sleep apnea who are referred to Levanger Hospital for respiratory polygraphy, and their partners

You may qualify if:

  • referred to the pulmonology department in the participating hospital (Sykehuset Levanger) with suspected sleep apnea
  • able to sign an informed consent

You may not qualify if:

  • Pregnancy
  • Serious disease which could affect ability to complete the study
  • Complicated sleep disorders

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Department of Pulmonology, Levanger Hospital, North Trøndelag Hospital Trust

Levanger, Norway

Location

MeSH Terms

Conditions

Sleep Apnea, Obstructive

Condition Hierarchy (Ancestors)

Sleep Apnea SyndromesApneaRespiration DisordersRespiratory Tract DiseasesSleep Disorders, IntrinsicDyssomniasSleep Wake DisordersNervous System Diseases

Study Officials

  • Øystein Risa, PhD

    NTNU, Fac of Med and Health Sci, Dept of Circulation and Medical Imaging

    STUDY DIRECTOR
  • Carl Platou, MD

    North Trøndelag Hospital Trust

    STUDY DIRECTOR

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

September 9, 2021

First Posted

September 17, 2021

Study Start

September 1, 2021

Primary Completion

December 31, 2022

Study Completion

March 7, 2023

Last Updated

March 20, 2023

Record last verified: 2023-03

Locations